October 29, 2013
8:30–9 a.m. REGISTRATION AND CONTINENTAL BREAKFAST
9–9:05 a.m. WELCOME
9:05–9:30 a.m. KEYNOTE: The State of Cancer Care: Promises and Challenges
Harold Varmus, M.D., Director, National Cancer Institute
9:30–10:30 a.m. The State of Genomic Understanding
How advances in genomics and bioinformatics are providing us with unprecedented opportunities to understand cancer biology and "exceptional responders".
Tadd Lazarus, M.D., Chief Medical Officer, Qiagen Inc. (Moderator)
Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School Director Emeritus, Harvard Medical School-Partners HealthCare Center for Personalized Genetic Medicine
David Solit, M.D., Elizabeth and Felix Rohatyn Chair, Department of Medicine and the Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center
10:30–10:45 a.m. BREAK
10:45–11:50 a.m. Detection and Prognosis: The Cutting Edge
How innovations in diagnostics technologies will transform cancer detection and care.
Paul Billings, M.D., Ph.D., Chief Medical Officer, Life Technologies Corp. (Moderator)
Luis Diaz Jr., M.D., Associate Professor of Oncology and Director of Translational Medicine, Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center
David Rimm, M.D., Ph.D., Professor of Pathology, Director of Pathology Tissue Services, and Director of Translational Pathology, Yale University
Laura van 't Veer, Ph.D., Leader, Breast Oncology Program and Associate Director, Applied Genomics, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center
Victor Velculescu, M.D., Ph.D., Professor of Oncology, Director of Cancer Genetics, Ludwig Center at Johns Hopkins, Co-director of Cancer Biology, Johns Hopkins Kimmel Cancer Center
11:50 a.m.-12 p.m. Special Recognition
Jack Andraka, winner 2012 Gordon E. Moore Award, the grand prize of the Intel International Science and Engineering Fair, for his "new method to detect pancreatic cancer".
12-1:30 p.m. LUNCHEON KEYNOTE: Path to Personalized Medicine - Where Are We Today?
Francis Collins, M.D., Ph.D, Director of the National Institutes of Health
Margaret Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration
A conversation on the state of personalized medicine moderated by Charles Sawyers, M.D., President, American Association for Cancer Research, Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
1:30–1:45 p.m. BREAK
1:45–3 p.m. Ensuring Patient Safety and Innovation
How diagnostics regulatory pathways can promote patient safety and innovation.
Daniel Hayes, M.D., Professor, Department of Internal Medicine, Stuart B. Padnos Professor of Breast Cancer Research, Clinical Director, Breast Oncology Program, University of Michigan (Moderator)
Tracy Bush, Ph.D., Director and Global Coordinator of Companion Diagnostics Regulatory Affairs, Roche Diagnostics
Elizabeth Mansfield, Ph.D., Director, Personalized Medicine Staff, Center for Devices and Radiological Health, Food and Drug Administration
Vincent Miller, M.D., Chief Medical Officer, Foundation Medicine
Ellen Sigal, Ph.D., Founder and Chair, Friends of Cancer Research
3–4:15 p.m. Ensuring Patient Access to Innovative Diagnostics
How current payment systems value new diagnostic technologies and affect physician and patient access
Louis Jacques, M.D., Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services
John Powderly, M.D., Founder, Carolina BioOncology Institute
Michele Schoonmaker, Vice President of Government Affairs, Cepheid
4:15 p.m. CLOSING REMARKS